PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mechanism discovered for how amyotrophic lateral sclerosis mutations damage nerve function

A study led by St. Jude Children's Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS

2014-02-05
(Press-News.org) Contact information: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital
Mechanism discovered for how amyotrophic lateral sclerosis mutations damage nerve function A study led by St. Jude Children's Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS (MEMPHIS, Tenn. – February 5, 2014) St. Jude Children's Research Hospital scientists led a study showing that mutations in a gene responsible for amyotrophic lateral sclerosis (ALS) disrupt the RNA transport system in nerve cells. The findings appear in the current issue of the scientific journal Neuron and offer a new focus for efforts to develop effective treatments.

The findings offer a new avenue for researchers to pursue in the quest for desperately needed treatments for ALS, a disorder that kills most patients within five years of diagnosis. ALS, also known as Lou Gehrig's disease, is diagnosed in about 5,600 individuals nationwide each year and is associated with muscle weakness and paralysis.

The gene, TDP-43, carries instructions for making a protein of the same name. While mutations in TDP-43 were known to cause ALS and a related neurodegenerative disorder, until now the mechanism involved was a mystery. This study showed for the first time that the mutations disrupt efficient movement within nerve cells of RNA molecules. These RNA molecules direct protein assembly based on instructions carried in DNA. Correct transport of these RNAs permits proteins to be made in the right place at the right time.

Working in motor neurons derived from patients with ALS, researchers demonstrated that each of three different TDP-43 mutations impaired delivery of RNA molecules to their final destination near the junction where a nerve and its target muscle meet. Without the RNA molecules, nerves cannot make proteins necessary to function normally and respond quickly when stimulated. Motor neurons govern movement, including breathing. Their death and deterioration is a hallmark of ALS.

The results also provide insight into how problems in RNA metabolism, including disturbances in RNA regulation and functioning, lead to ALS and other neurodegenerative diseases.

"Five years of tremendous progress in ALS genetics has revealed that RNA metabolism is a critical pathway that is impaired in this disease," said the study's corresponding author J. Paul Taylor, M.D., Ph.D., a member of the St. Jude Department of Developmental Neurobiology. "But RNA metabolism is a complex process that involves multiple steps that are carried out in different parts of the cell. This study provides a more refined understanding of how ALS-causing mutations impair RNA metabolism so we know what needs fixing therapeutically."

TDP-43 belongs to a family of proteins that bind to RNA and regulate its function. Normally TDP-43 is stored in the cell's command center, the nucleus. There the protein prepares DNA for translation into the proteins that do the work of cells and shuttles the resulting RNA, called mRNA, from the nucleus to the cytoplasm, the cell's liquid center. While clumps of TDP-43 were known to accumulate in the cytoplasm of the motor neurons of patients with ALS and other neurodegenerative diseases, the protein's function there was unknown.

This study provides an answer. The work was done in motor neurons from the fruit fly Drosophila melanogaster, mouse brain cells and human motor neurons produced by reprogramming cells from ALS patients with three different TDP-43 mutations. Co-first author Nael Alami, Ph.D., a postdoctoral fellow in Taylor's laboratory, developed a florescent RNA beacon that let investigators track movement of RNA molecules in living cells.

Researchers demonstrated that TDP-43 is part of a molecule called an RNA transport granule. These granules are responsible for moving mRNA efficiently to the end of the axon where the molecule is translated into a protein. For this study, scientists used Neurofilament-L (NEFL) mRNA, which is known to bind TDP-43.

In human motor neurons growing in the laboratory, investigators found that transport granules with mutant TDP-43 were more likely than granules with unaltered TDP-43 to stall en route to the nerve ending and sometimes reverse direction. The defect in the human ALS motor neurons was apparent after the first week.

Evidence from mice suggests TDP-43 mutations selectively rather than globally disrupt movement in nerve cells. The mutations did not affect movement of another cell structure, the mitochondria, along the axon where mRNA movement was impaired.

"We know neurodegenerative disorders, including Parkinson's and Alzheimer's diseases, seem to share a common mechanism," Alami said. "We plan to use our finding from this study to look for similar defects in those diseases."

### Rebecca Smith, Ph.D., formerly of St. Jude, is co-first author of the study. The other authors are Monica Carrasco and Tom Maniatis, both of Columbia University Medical Center, New York; Luis Williams, Steve Han, Evangelos Kiskinis and Kevin Eggan, all of Harvard University, Cambridge, Mass.; Christina Winborn and Edward Chaum, both of the University of Tennessee Health Science Center, Memphis; Brett Winborn, Brian Freibaum, Anderson Kanagaraj and Nisha Badders, all of St. Jude; Alison Clare, formerly of St. Jude; Bilada Bilican and Siddharthan Chandran, University of Edinburgh, United Kingdom; and Christopher Shaw, King's College London.

The research was funded in part by the Packard Foundation, the Muscular Dystrophy Association; the ALS Association, grants (NS053825 and AG031587) from the National Institutes of Health, a grant (CA021765-34) from the National Cancer Institute, which is part of NIH, and ALSAC.

St. Jude Media Relations Contacts

Carrie Strehlau
desk: (901) 595-2295
cell: (901) 297-9875
carrie.strehlau@stjude.org

Summer Freeman
desk: (901) 595-3061
cell: (901) 297-9861
summer.freeman@stjude.org


ELSE PRESS RELEASES FROM THIS DATE:

Pinpointing the brain's arbitrator

2014-02-05
We tend to be creatures of habit. In fact, the human brain has a learning system that is devoted to guiding us through routine, or habitual, ...

Study untangles divergent US job-tenure patterns

2014-02-05
WASHINGTON, DC, February 5, 2014 — Have American jobs become less stable? Do workers change ...

Predicting cardiovascular events in sleep apnea

2014-02-05
Obstructive sleep apnea (OSA) generally is associated with increased risk for cardiovascular (CV) disease. OSA is usually measured using the apnea-hypopnea index (AHI), the number of times that breathing pauses or severely slows per hour of sleep. ...

Educational toolkit did not improve quality of care or outcomes for patients with diabetes

2014-02-05
An educational toolkit designed to improve care of patients with diabetes was not effective, Baiju R Shah and colleagues (University of Toronto) found in a cluster randomized trial conducted in 2009-2011. ...

Pattern of higher blood pressure in early adulthood helps predict risk of heart disease

2014-02-05
In an analysis of blood pressure patterns over a 25-year span from young adulthood to middle age, individuals who exhibited elevated and increasing blood pressure levels ...

Study shows potential usefulness of non-invasive measure of heart tissue scarring

2014-02-05
Scarring of tissue in the upper chamber of the heart (atrium) was associated with recurrent rhythm disorder after treatment, according to a study in the February 5 issue of JAMA. ...

Pre-term infants with severe retinopathy more likely to have non-visual disabilities

2014-02-05
In a group of very low-birth-weight infants, severe retinopathy of prematurity was associated with nonvisual disabilities at age 5 years, according to a study in the February ...

Do you have a sweet tooth? Honeybees have a sweet claw

2014-02-05
New research on the ability of honeybees to taste with claws on their forelegs reveals details on how this information is processed, according to a study published in the open-access journal, Frontiers in Behavioral Neuroscience. Insects ...

Clearer labels needed on drugs containing animal products

2014-02-05
Dr Kinesh Patel and Dr Kate Tatham say most medications prescribed in primary care contain animal derived products and it ...

Is institutional racism happening in our hospitals?

2014-02-05
Dr Nadeem Moghal, from George Eliot Hospital in Warwickshire, draws on the Macpherson report (the police ...

LAST 30 PRESS RELEASES:

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

[Press-News.org] Mechanism discovered for how amyotrophic lateral sclerosis mutations damage nerve function
A study led by St. Jude Children's Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS